General information

Announcements(1)

Program

Sessions

Search presentations

Download PDF for print

Timetable

Mon. Mar 17, 2025

Tue. Mar 18, 2025

Wed. Mar 19, 2025

web_header_en.png

web_icon.png

Profile management

Announcements

Bookmark

Program Type

Login required to view

Password required to view

Presentation Information

Session Details

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

A novel NRF2 activator added to angiotensin receptor blocker attenuates progressive phenotype in Experimental Alport Syndrome

Drug development for chronic kidney disease is a major societal challenge. To date, pharmacological drug discovery strategies of national and international pharmaceutical companies have been developed using mouse models of Alport syndrome. In this symposium, international Alport syndrome researchers will present their latest research findings and discuss drug discovery strategies.

Updated issues on Alport syndrome research

APPW2025

Presentation Information

[[OD]3S13m-5]A novel NRF2 activator added to angiotensin receptor blocker attenuates progressive phenotype in Experimental Alport Syndrome

Login required to view

Comment